• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec9
Noble Financial Reiterates Buy Rating on Neurosense Therapeutics
14:37
Oct16
Analyst LeBoyer covers healthcare sector focusing on specific stocks
11:11
Aug2
NeuroSense Therapeutics - Unit released FY2025 Q1 earnings on August 1 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.095 (forecast USD -0.105)
03:00
NeuroSense Therapeutics - Unit released FY2025 Q2 earnings on August 1 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.0926 (forecast USD -0.37)
03:00
NeuroSense Therapeutics - Unit released FY2025 Semi-Annual Earnings on August 1 (EST), with actual revenue of USD 0 and actual EPS of USD -0.1853
03:00
Jun26
NeuroSense Completes Pre-IND Meeting for ALS Treatment PrimeC
13:16

Schedules & Filings

Schedules
Filings
Aug1
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -2.355 M, EPS -0.0926

Apr7
Earning Release(EST)

FY2024 Q4 Earning Release (USD) Net Income -1.801 M, EPS -0.0831

Dec18
Earning Release(EST)

FY2024 Q3 Earning Release (USD) Net Income -2.148 M, EPS -0.1118

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
PCLA
0.3600
+192.45%
+0.237
STEC
1.530
+59.38%
+0.570
HIHO
1.250
+50.60%
+0.420
TRIB
1.280
+43.50%
+0.388
EUDA
1.920
+41.18%
+0.560
AFJK
44.010
+37.49%
+12.000
SOC
10.360
+36.32%
+2.760
POM
0.3499
+30.95%
+0.083
ASTI
5.060
+30.41%
+1.180
ASPC
16.100
+29.42%
+3.660
View More